Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines
- Type
- Retraction
- Notice date
- 2/5/2024 0:00
- Journal
- PLoS One
- Publisher
- PLoS
- Notice DOI
- 10.1371/journal.pone.0298557
- Original paper DOI
- 10.1371/journal.pone.0053645